End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
231.5 MXN | -3.73% |
|
-3.73% | -3.42% |
06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 4502 Stock
- TAK N Stock
- Revisions Takeda Pharmaceutical Company Limited